Governance
ALISEI's governance system is based on a Steering Committee composed of a President, a Vice-President and three Commissioners.

Alessandra Gelera holds a degree in Chemistry and Pharmaceutical Sciences and a postgraduate Master's in Health Economics, which marked the beginning of her nearly 20-year professional career in the Life Sciences supply chain. She currently serves as Head of Public Affairs, Health Economics & Market Access (HEMA) at Boston Scientific (Italy), a multinational and industry leader in medical devices with a strong commitment to public-private collaboration—from professional training to the promotion of cross-sectoral projects supporting both public and private institutions.
Alessandra Gelera actively collaborates with patient associations, driven by her desire to contribute, as a citizen, to the development of organizations capable of representing the interests of the population and generating value for the health of current and future generations.
She has also championed numerous initiatives within the Confindustria system, actively contributing to proposals and projects. These efforts led to her appointment—and subsequent confirmation for the 2024–2027 term—as Coordinator of the Life Sciences Supply Chain of Assolombarda and as Assolombarda’s representative within Confindustria’s Technical Group on Life Sciences, alongside high-level figures such as the Vice President of Assolombarda with responsibility for Life Sciences and the Special Advisor for Life Sciences at Confindustria.
Given her current professional background, Alessandra is also involved in the activities of Confindustria Dispositivi Medici.

Alberta Pasquero has been CEO of Bio Industry Park Silvano Fumero S.p.A., a Benefit Corporation, since July 2012. She is an expert in financial projects funded through European and national programs in the areas of equal opportunities and local development. She works as a consultant for public and private entities to implement socially responsible programs and policies, particularly in the redevelopment of industrial sites and logistics.She is President of the Group of Women Entrepreneurs and Executives for the Canavese area and Chair of the Health and Life Sciences Commission of Confindustria Piemonte.

Giuseppe Antonio Pablo Cirrone is a Nuclear Physicist. In 1998, he was admitted to the Specialization School in Medical Physics at the University of Florence, where he earned the title of Qualified Medical Physicist in 2000 with a thesis on the use of natural and synthetic diamond as a dosimetric system for ionizing radiation.He earned his PhD in 2003 with a dissertation on the use of the Geant4 Monte Carlo code in hadrontherapy applications.Since 2007, he has been responsible for the proton therapy beamline and the interdisciplinary beamline at the INFN’s Laboratori Nazionali del Sud, where he coordinates and supports various experimental groups.Since 2012, he has led the ELIMED project (ELI-Beamline MEDical applications) and currently serves as the local Coordinator of INFN’s Multidisciplinary Committee.He is President of the Technical Committee of the COMETA Consortium, a national research body dedicated to high-performance computing, and is a member of scientific and organizational committees for national and international conferences.

Project Manager and Innovation Specialist with over 15 years of experience in coordinating high-impact research and development projects, with a focus on strengthening regional innovation capacity in the Life Sciences sector.She is an expert in risk management and quality assurance across all phases of project execution, ensuring tangible and sustainable outcomes.Roberta has proven expertise in fostering interregional and transnational collaborations, facilitating the engagement of public and private stakeholders, and supporting the creation of complex innovation ecosystems. She has solid experience in consortium management, data analysis, and survey design, with a strategic approach focused on technology transfer and innovation.

Graduated in Law from the “La Sapienza” University of Rome.He has been with Confindustria since 2000, working on labor and trade union matters. He is currently an Adviser for Life Sciences at Confindustria, focusing on health policies and supplementary healthcare.
